Business & Regulation

We dive into the archive of 2018 for insight and inspiration – this time with Bruno Sepodes

EFPIA signs joint declaration championing open trade in the EU.

Counterfeit medicines pose a significant threat to global health. A recent study uncovers alarming facts and emphasizes the need for solutions.

The public’s perception of the industry is low. How can we fix it?

Delali Attipoe at the DNDi explains why we need an R&D model attuned to the needs of forgotten patients.

Looking for words of wisdom and tips on being a leader and advancing your career in pharma?

As part of our 10-year anniversary special feature, Markus Kosch tells us his views on the future of pharma.

What does the future hold for pharma? Audrey Greenberg and Jon Zwinski give their views.

It’s time to go back to basics when it comes to pharmaceutical supply chains and preventing shortages.

Why some stakeholders are not happy about the FDA’s removal of tirzepatide from the drug shortage list.